Cytokinetics, Incorporated (CYTK) Cash Flow Statement
Cytokinetics, Incorporated (CYTK) generated -$555.5M of operating cash flow over the twelve months to 2026-06-30, spent $25.3M on capital expenditure and had free cash flow of -$580.7M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CYTKCytokinetics, IncorporatedFollow CYTK — free
—
Price chart with a free account
- Market cap
- 8.5B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -0.05 | -0.03 | -0.01 | -0.04 | 0.00 | 0.04 | -0.10 | -0.10 | -0.09 | 0.01 | -0.14 | -0.30 | -0.41 | -0.40 | -0.51 | -0.56 | |
| Capital expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.05 | 0.01 | 0.00 | 0.00 | 0.02 | -0.03 | |
| Free cash flow | -0.05 | -0.03 | -0.01 | -0.05 | 0.00 | 0.04 | -0.10 | -0.10 | -0.09 | -0.00 | -0.19 | -0.31 | -0.42 | -0.40 | -0.53 | -0.58 | |
| Stock-based compensation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.05 | 0.07 | 0.10 | 0.11 | — |
USD billions · SEC XBRL
Cytokinetics, Incorporated — questions
- What is Cytokinetics, Incorporated's operating cash flow?
- -$555.5M over the twelve months to 2026-06-30.
- How much does Cytokinetics, Incorporated spend on capital expenditure?
- $25.3M over the twelve months to 2026-06-30.
- What is Cytokinetics, Incorporated's free cash flow?
- -$580.7M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Cytokinetics, Incorporated's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.